nilotinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

National Cancer Institute (NCI) (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadneutrophil count

I am/have/hadsmall intestine

I am/have/hadmetastasis

I am/have/hadparathyroid gland

I am/have/hadgastrointestinal stromal tumor

I am/have/hadpleural mesothelioma

I am/have/hadvulvar cancer

I am/have/hadadenoid cystic carcinoma

I am/have/hadpalliative radiation therapy

I am/have/hadchordoma

I am/have/hadliver metastases

I am/have/hadurine test

I am/have/hadlepidic predominant adenocarcinoma

I am/have/hadpancreatic neuroendocrine tumor

I am/have/hadmajor surgery

I am/have/hadcarcinoid

I am/have/hadmixed mullerian tumors

I am/have/hadsarcoma

I am/have/hadspindle cell carcinoma of kidney

added new label for I am/have/had

more

I am looking for

I am looking fornilotinib

I am looking fornitrosoureas

I am looking forepinephrine

I am looking formitomycin

I am looking foradrenal

I am looking forantineoplastic agents

I am looking forbisphosphonate

I am looking forpaclitaxel

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel

Participants will repeat the screening tests during the study. Participants will receive nilotinib and paclitaxel. The drugs are given in 28-day cycles. Nilotinib is a capsule taken by mouth twice a day. Paclitaxel will be given intravenously by peripheral line or central line once a week for the first 3 …

mucinous adenocarcinoma

carcinoid

acinar cell carcinoma

neuroendocrine tumor

ovarian cancer

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.